Shared on 18 Sep 25Fair value Increased 11%Upward revisions in both expected revenue growth and net profit margin have driven analysts to raise Esprinet’s consensus price target from €6.17 to €6.83. Valuation Changes Summary of Valuation Changes for Esprinet The Consensus Analyst Price Target has significantly risen from €6.17 to €6.83.Read more0 votesShareShared on 01 May 25Fair value Decreased 4.69%Read more0 votesShareShared on 23 Apr 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 17 Apr 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 09 Apr 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 02 Apr 25Fair value Increased 0.94%AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 26 Mar 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 19 Mar 25Fair value Increased 3.95%AnalystConsensusTarget has decreased revenue growth from 5.0% to 3.0% and decreased discount rate from 17.2% to 14.4%.Read more0 votesShareShared on 12 Mar 25Read more0 votesShare